COCRYSTAL PHARMA, INC. Earnings Per Share (Basic)
COCRYSTAL PHARMA, INC. (COCP) reported Earnings Per Share (Basic) of -$0.23 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.23.
- COCRYSTAL PHARMA, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.17.
- COCRYSTAL PHARMA, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.19.
- COCRYSTAL PHARMA, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.20.
- COCRYSTAL PHARMA, INC. earnings per share, basic for fiscal 2025 was -$0.78.
- COCRYSTAL PHARMA, INC. earnings per share, basic for fiscal 2024 was -$1.72.
- COCRYSTAL PHARMA, INC. earnings per share, basic for fiscal 2023 was -$1.87.
- COCRYSTAL PHARMA, INC. earnings per share, basic for fiscal 2022 was -$4.77.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.23 10-Q · filed 2026-08-13 | -$0.40 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$0.17 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | -$0.78 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-14 | -$0.61 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | -$0.20 10-Q · filed 2026-08-13 | -$0.43 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$0.23 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | -$1.72 10-K · filed 2026-03-31 | |||||||
| 2024-09-30 | -$0.49 10-Q · filed 2025-11-14 | -$1.40 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | -$0.53 10-Q · filed 2025-08-14 | -$0.91 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | -$0.39 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | -$1.87 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | -$0.41 10-Q · filed 2024-11-13 | -$1.43 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | -$0.41 10-Q · filed 2024-08-14 | -$1.03 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.64 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | -$4.77 10-K · filed 2024-03-28 | |||||||
| 2022-09-30 | -$0.70 10-Q · filed 2023-11-13 | -$4.23 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | -$3.00 10-Q · filed 2023-08-14 | -$0.25 10-Q · filed 2022-08-15 | -$3.48 10-Q · filed 2023-08-14 | -$0.29 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | -$0.52 10-Q · filed 2023-05-15 | -$0.04 10-Q · filed 2022-05-11 | ||||||
| 2021-12-31 | -$0.16 10-K · filed 2023-03-29 | |||||||
| 2021-09-30 | -$0.48 10-Q · filed 2022-11-14 | -$1.44 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.04 10-Q · filed 2022-08-15 | -$0.08 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$0.04 10-Q · filed 2022-05-11 | |||||||
| 2020-06-30 | -$0.12 10-Q · filed 2020-08-06 | |||||||
| 2020-03-31 | -$0.05 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | -$1511.94 derived: net income ÷ weighted average shares · filed 2020-03-27 | |||||||
| 2019-06-30 | $0.05 10-Q · filed 2020-08-06 | |||||||
| 2019-03-31 | $0.10 10-Q · filed 2020-05-13 | |||||||
| 2018-12-31 | -$1751.15 derived: net income ÷ weighted average shares · filed 2020-03-27 | |||||||
| 2018-09-30 | -$0.06 10-Q · filed 2018-11-09 | -$0.17 10-Q · filed 2018-11-09 | ||||||
| 2018-06-30 | -$0.05 10-Q · filed 2018-08-09 | -$0.11 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$0.06 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | $0.20 10-K · filed 2018-03-21 | -$0.03 10-K · filed 2018-03-21 | ||||||
| 2017-09-30 | -$0.08 10-K · filed 2018-03-21 | $0.00 10-Q · filed 2017-11-08 | -$0.24 10-Q · filed 2018-11-09 | -$0.01 10-Q · filed 2017-11-08 | ||||
| 2017-06-30 | -$0.09 10-Q · filed 2018-11-09 | $0.00 10-Q · filed 2017-08-08 | -$0.15 10-Q · filed 2018-08-09 | -$0.01 10-Q · filed 2017-08-08 | ||||
| 2017-03-31 | -$0.11 10-Q · filed 2018-05-10 | $0.00 10-Q · filed 2017-05-10 | ||||||
| 2016-12-31 | -$3.06 10-K · filed 2018-03-21 | -$0.10 10-K · filed 2017-03-31 | -$3.18 10-K · filed 2018-03-21 | -$0.11 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | -$0.03 10-K · filed 2018-03-21 | $0.00 10-Q · filed 2016-11-09 | -$0.01 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | -$0.14 10-K · filed 2018-03-21 | $0.00 10-Q · filed 2016-08-09 | -$0.01 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | -$0.17 10-K · filed 2018-03-21 | -$0.01 10-Q · filed 2016-05-10 | ||||||
| 2015-12-31 | -$0.05 10-K · filed 2017-03-31 | -$2.40 10-K · filed 2018-03-21 | -$0.08 10-K · filed 2016-03-15 | |||||
| 2015-09-30 | $0.00 10-K · filed 2017-03-31 | -$0.03 10-Q · filed 2016-11-09 | ||||||
| 2015-06-30 | $0.00 10-K · filed 2017-03-31 | -$0.03 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | -$0.03 10-K · filed 2017-03-31 | -$0.04 10-Q · filed 2016-05-10 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-31 | |||||||
| 2014-09-30 | -$0.01 10-Q · filed 2015-11-16 | -$8.15 derived: net income ÷ weighted average shares · filed 2015-11-16 | $0.01 10-Q · filed 2015-11-16 | |||||
| 2014-06-30 | $0.01 10-Q · filed 2015-08-14 | $0.01 10-Q · filed 2015-08-14 | ||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | |||||||
| 2013-12-31 | -$0.07 10-K · filed 2015-03-31 | -$0.33 10-K · filed 2014-03-31 | ||||||
| 2013-09-30 | -$0.02 10-Q · filed 2014-11-14 | -$0.08 10-Q · filed 2013-11-18 | -$35.54 derived: net income ÷ weighted average shares · filed 2014-11-14 | -$0.05 10-Q · filed 2014-11-14 | -$0.12 10-Q · filed 2013-11-18 | |||
| 2013-06-30 | -$0.02 10-Q · filed 2014-08-14 | -$0.01 10-Q · filed 2013-08-15 | -$0.04 10-Q · filed 2014-08-14 | -$0.03 10-Q · filed 2013-08-15 | ||||
| 2013-03-31 | -$0.02 10-Q · filed 2014-05-15 | |||||||
| 2012-12-31 | -$0.13 10-K · filed 2014-03-31 | |||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-18 | -$0.07 10-Q · filed 2013-11-18 | ||||||
| 2012-06-30 | -$0.01 10-Q · filed 2013-08-15 | -$0.03 10-Q/A · filed 2012-09-06 | -$0.08 10-Q · filed 2013-08-15 | -$0.19 10-Q/A · filed 2012-09-06 | ||||
| 2012-03-31 | -$0.06 10-Q · filed 2013-05-10 | |||||||
| 2011-12-31 | -$0.11 10-K · filed 2013-04-01 | |||||||
| 2011-09-30 | -$0.04 10-Q · filed 2012-11-14 | -$0.07 10-Q · filed 2012-11-14 | ||||||
| 2011-06-30 | -$0.01 10-Q/A · filed 2012-09-28 | -$0.03 10-Q/A · filed 2012-09-28 | ||||||
| 2011-03-31 | $0.00 10-Q/A · filed 2012-10-02 | |||||||
| 2010-12-31 | -$0.01 10-K · filed 2012-04-16 | |||||||
| 2010-09-30 | $0.01 10-Q · filed 2011-11-21 | $0.01 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-09 | $0.00 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |